Sigma Planning Corp
CYTK icon

Sigma Planning Corp’s Cytokinetics CYTK Stock Holding History

Sigma Planning Corp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,724
Closed -$232K – 1354
2026
Q2 		$232K Buy
+2,724
New +$196K 0.01% 1243
2020
Q3 		– Sell
-9,700
Closed -$229K – 1081
2020
Q2 		$229K Buy
+9,700
New +$182K 0.01% 887

Other funds holding CYTK

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.9B AUM 30.31% 1-Year Est. Return

Sigma Planning Corp's CYTK Position: Q3 2026 in Review

Sigma Planning Corp sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 2,724 shares — an estimated $232K sold.

Sigma Planning Corp first reported a position in CYTK in Q2 2020 and held it in 2 quarters. The position peaked at $232K in Q2 2026. 140 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Sigma Planning Corp reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 2,724 Cytokinetics shares in Q3 2026, an estimated $232K.
  • Sigma Planning Corp first reported a position in Cytokinetics in Q2 2020 and held it in 2 quarters.
  • Sigma Planning Corp's Cytokinetics position peaked at $232K in Q2 2026.
  • 140 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.